Morgan Stanley analyst Simeon Gutman raised the firm’s price target on Sally Beauty (SBH) to $16 from $14 and keeps an Underweight rating on the shares. While benefits from strategic initiatives should continue throughout FY26, medium-term EBIT growth is likely limited as cost savings wind down and expenses normalize, the analyst tells investors in a post-earnings note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SBH:
- Sally Beauty price target raised to $20 from $18 at TD Cowen
- Sally Beauty: Early-Stage Growth Initiatives and Margin Expansion Underpin Buy Rating and Raised $20 Price Target
- Sally Beauty price target raised to $20 from $19 at Canaccord
- Compelling Value Amid Strategic Modernization and Resilient Profitability Supporting Double-Digit EPS Growth
- Sally Beauty Earnings Call Balances Progress With Caution